Celltrion
068270.KS
#774
Rank
C$35.87 B
Marketcap
$173.22
Share price
1.34%
Change (1 day)
-3.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - P/B ratio

P/B ratio as of November 2024 : 2.09

According to Celltrion 's latest financial reports the company has a price-to-book ratio of 13.0575.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Celltrion - P/B ratio (from 2007 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-312.53-52.72%
2022-12-315.35-21.48%
2021-12-316.81-52.34%
2020-12-3114.378.33%
2019-12-318.01-24.98%
2018-12-3110.7-6.16%
2017-12-3111.479.03%
2016-12-316.3613.97%
2015-12-315.5889.56%
2014-12-312.94-14.92%
2013-12-313.46-19.46%
2012-12-314.30-10.79%
2011-12-314.81-3.36%
2010-12-314.98-6.24%
2009-12-315.3116.53%
2008-12-314.56580.72%
2007-12-310.6699